Screener
VolitionRX Limited VNRX Q1 2026 Annual earnings
Reported May 14, 2026 · After market close
Revenue$985.1KMiss by $534.2K
EPS-$0.97Miss by $0.27
Revenue estimate$1.5M
EPS estimate-$0.70
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$706.4K
EPS estimate-$0.38
Versus estimates
Revenue
Diluted EPS
FAQ
- When did VolitionRX Limited report Q1 2026 earnings?
- VolitionRX Limited (VNRX) reported Q1 2026 earnings on May 14, 2026 after market close.
- What were VolitionRX Limited's Q1 2026 revenue and EPS?
- VolitionRX Limited reported revenue of $985.1K and eps of $-0.97 for Q1 2026.
- Did VolitionRX Limited beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $1.5M by $534.2K. EPS missed the consensus estimate of $-0.70 by $0.27.
- How did VolitionRX Limited's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 299.8% from $246.4K a year earlier and eps declined 1516.7% from $-0.06.
- Where can I find VolitionRX Limited's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001477932-26-003126) and the 10-K periodic report (0001477932-26-001832) directly on SEC EDGAR. The filing index links above go to sec.gov.
